Two oral therapies for COVID-19 were recently approved. Listen in as we discuss who is eligible to receive them, their efficacy, and what this means for the future of COVID-19 treatment.
Guest:
Patrick Kinn, PharmD, MPH, BCPS
Clinical Pharmacy Specialist - Infectious Disease
University of Iowa Health Care
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc
Redeem your CPE or CME credit here!
Pharmacist members
CME
Need a membership?
Join for CPE Credit
Join for CME Credit
References and resources:
Continuing Education Information:
Learning Objectives:
Dr. Wall is a member of the Janssen Speaker's Bureau.
Dr. Galdo reports no actual or potential conflicts of interest associated with this episode.
Dr. Kinn reports no actual or potential conflicts of interest associated with this episode.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-056-H01-P
Initial release date: 01/17/22
Expiration date: 01/17/2023
Additional CPE & CME details can be found here